Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T14:27:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and the notices for v3.4.1 and the lapse in government funding have been removed; these are minor site maintenance updates and do not alter study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T02:13:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-03T23:53:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary toggle (Show glossary / Hide glossary) and includes minor textual updates for QC criteria labeling and FEAR Act Data capitalization. It also shows the new footer revision note 'Revision: v3.4.0' (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-27T22:38:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Updated the site revision from v3.3.3 to v3.3.4. No user-facing content or core functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-01-13T19:16:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section has been expanded to list numerous study sites across the United States (AL, CA, CO, FL, GA, IN, KS, KY, MD, MI, MO, NY, OH, RI, TN, TX), Canada (AB, NB, ON, QC), Japan (Aichi-ken, Hiroshima, Hokkaido, Kanagawa, Osaka, Tokyo), and Spain (Catalonia, Valencia). The page revision also updates to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T09:01:04.000Z thumbnail image

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.